Spero Therapeutics

Multi-Asset, clinical-stage biopharmaceutical company focused on multidrug-resistant bacterial infections.

HQ location

Cambridge, United States

Website

sperotherapeutics.com

Launch date

Mar 2013

Employees

Market cap

Enterprise value

$84m

Share price

$2.00 SPRO

https://twitter.com/spero_tx https://www.linkedin.com/company/spero-therapeutics

Authorizing premium user...